RAC 3.79% $1.53 race oncology ltd

Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-39

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 19,369 Posts.
    lightbulb Created with Sketch. 6494
    That is because you are not looking at the Phase 1 results for this trial. The results you are quoting was from a different and earlier trial.

    I think you would find it worthwhile learning more about Race and Bisantrene.
    Last edited by Davisite: 06/11/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.